ArborGen Holdings Limited

ArborGen Holdings Limited

ARB.NZ
ArborGen Holdings LimitedNZ flagNew Zealand Exchange
0.09
NZD
+0.00
- -
46.13MMarket Cap
ArborGen Holdings Limited
ARB.NZ
(New Zealand Exchange)

Recent

price

0.09

P/E

ratio

- -

div

yld

- -

ROIC.AI

2006
2007
2010
2011
2012
2013
2014
2015
2016
2019
2020
2021
2022
2023
2024
2025
FRC
1.56
1.59
1.71
1.24
1.46
1.23
1.21
1.19
1.48
0.15
0.19
0.15
0.14
0.18
0.22
0.21
Revenue per Share
0.01
- -
-0.01
-0.02
-0.04
-0.02
-0.01
- -
-0.08
-0.01
-0.01
0.01
- -
-0.01
- -
-0.07
Basic EPS, GAAP
-0.1
0.02
0.04
- -
-0.04
-0.04
0.01
-0.02
0.09
-0.02
-0.03
-0.01
-0.01
-0.02
-0.02
-0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.75
0.66
0.79
0.56
0.61
0.51
0.48
0.46
0.49
0.44
0.49
0.43
0.43
0.47
0.49
0.42
Book Value per Share
0.64
0.51
0.58
0.4
0.37
0.29
0.29
0.26
0.27
0.12
0.13
0.13
0.01
0.01
0.01
0.22
Tangible Book Value per Share
319
293
278
317
286
380
375
500
409
497
498
500
501
502
506
524
Basic Weighted Avg Shares
498
464
475
393
419
466
452
597
607
72
95
76
68
89
113
111
Sales/Revenue/Turnover
2.97
2.79
-0.61
-1.84
-3.59
-1.37
- -
1.72
3.95
-0.2
-13.01
-15.94
-18.91
2.32
-6.06
-52.06
Operating Margin (%)
8
9
9
7
6
5
5
4
4
13
16
15
39
16
19
28
Depreciation Expense
2
-1
-3
-6
-10
-6
-3
1
-34
-6
-4
5
2
-4
- -
-38
Net Income, GAAP
37.5
50
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
377.78
- -
- -
Effective Tax Rate (%)
0.33
-0.28
-0.61
-1.53
-2.4
-1.37
-0.76
0.25
-5.58
-8.76
-4.75
6.07
3.57
-4.46
-0.3
-34.02
Profit Margin (%)
134
27
140
112
122
157
142
212
107
38
42
53
101
114
111
90
Working Capital
59
- -
36
37
71
74
66
109
49
41
59
54
43
35
40
51
LT Debt
322
261
284
228
212
219
206
257
186
217
236
212
144
152
156
218
Total Equity
2.96
2.01
- -
- -
- -
- -
- -
3.19
- -
- -
- -
- -
- -
-2.95
- -
- -
Return on Invested Capital (%)
-0.55
0.2
- -
- -
- -
- -
- -
1.62
- -
- -
- -
- -
- -
-3.71
- -
- -
Return on Capital (%)
0.62
-0.6
-1.4
-3.04
-5.68
-3.48
-1.85
0.71
-15.66
-3.04
-1.95
2.01
1.13
-1.75
-0.14
-16.12
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.29%
1.26%
40.37%
Free Cash Flow
-119.75%
4.75%
24.08%
Net Income, GAAP
787.86%
2,116.71%
11,186.84%
Sales/Revenue/Turnover
-0.11%
5.11%
-1.99%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
89
2024
- -
- -
- -
- -
113
2025
- -
- -
- -
- -
111

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.01
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
-0.07

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
ArborGen Holdings Limited ArborGen Holdings Limited (NZX: ARB.NZ) is a New Zealand-based holding company that operates as a global leader in advanced forestry genetics, primarily through its wholly owned subsidiary ArborGen, providing genetically improved tree seedlings to the commercial forestry industry. The company offers a range of high-value products including conventional and advanced genetic seedlings for species such as loblolly pine, slash pine, longleaf pine, radiata pine, and eucalyptus; these seedlings feature enhanced growth rates, yields, stress tolerance, disease resistance, and wood quality, produced across 14-16 commercial-scale nurseries and 10 seed orchards with an annual capacity of approximately 450-500 million seedlings, serving over 2,000 customers annually in key markets including the US South and Brazil. Operations focus on the forestry genetics segment, with additional engagement in emerging carbon markets through protocol development with carbon registries; facilities include world-class research centers in Summerville and Ridgeville, South Carolina, USA, multiple nurseries throughout the southeastern United States, and production sites in Brazil such as Telêmaco Borba and a new site in Teresina. Founded in 2001 and headquartered at 100 Parnell Road, Auckland, New Zealand, the company rebranded from Rubicon Limited in September 2019 to reflect its focus on ArborGen's core operations following the divestment of New Zealand and Australian businesses in 2021. Recent major developments include the completion of the USD$4 million sale of its in vitro services business in July 2024 to reduce debt and fund growth; the signing of a memorandum of understanding in October 2024 to acquire the Eco Empreendimentos nursery in Piauí, Brazil, for approximately USD$2.5 million to expand footprint; an acquisition of a eucalyptus nursery in Erval Grande, Brazil, in 2023; a share buyback program completed in January 2025 returning up to US$500,000 in capital; the appointment of a new Chief Financial Officer in 2024 and leadership changes including a new CEO in 2023; and strong FY25 results announced in May 2025 in line with guidance, alongside FY26 outlook emphasizing market opportunities in advanced genetics and carbon sequestration.